HIP1-ALK, a novel ALK fusion variant that responds to crizotinib
Journal of Thoracic Oncology (2014) - Comments
pubmed: 24496003  doi: 10.1097/jto.0000000000000087  issn: 1556-1380  issn: 1556-0864 

Douglas D. Fang, Bin Zhang, Qingyang Gu, Maruja Lira, Qiang Xu, Hongye Sun, Maoxiang Qian, Weiqi Sheng, Mark Ozeck, Zhenxiong Wang, Cathy Zhang, Xinsheng Chen, Kevin X. Chen, Jian Li, Shu-Hui Chen, James Christensen, Mao Mao, Chi-Chung Chan